Moderna to charge $25-$37 for Covid-19 vaccine: CEO

Cornelia Mascio
Novembre 22, 2020

Based on these interim safety and efficacy data, Moderna intends to submit for an Emergency Use Authorisation (EUA) with the US Food and Drug Administration (USFDA) in the coming weeks and anticipates having the EUA informed by the final safety and efficacy data.

No serious adverse reaction has been reported from those who received the vaccine in emergency use, Sinopharm said in an article on social media WeChat, citing Chairman Liu Jingzhen from a recent media interview.

So far, two companies developing COVID-19 vaccines, Pfizer/BioNTech and Moderna, have revealed analysis from late-stage studies of their respective candidates.

"For example, a transnational company has 99 employees in one of its overseas offices, of whom 81 were vaccinated".

The NHS' current plan for the COVID vaccine rollout - dependent on the arrival of supplies - would see the whole adult population able to begin receiving it before the end of January, according to leaked documents seen by the Healthcare Service Journal.

Dr. Andrew Pollard, an expert in pediatric infection and immunity at Oxford, said research was slowed by low infection rates over the summer, but the Phase III trials are now accumulating the data needed to report results as a renewed surge of the pandemic hits countries around the world.

Despite recent progress, Pollard said the world is still in the early stages of the effort to protect people against COVID-19.

The Oxford Vaccine (ChAdOx1 nCoV-19) was administered to 560 people in two standard doses.

After getting permission to use the experimental vaccine in China, the pharmaceutical company Can Sino Biologics announced that it has also received special permission to apply the experimental vaccine to Chinese army personnel.

China claims to have created a super vaccine from Corona.

But experts have cautioned against using data exclusively from emergency use programme, without comparable results from a clinical trial-standard control group, to determine a vaccine's effectiveness.

It's unclear which vaccine Liu referred to, and Sinopharm was not immediately available to comment.

Dr Anthony Fauci, the top United States infectious disease expert, said the Pfizer and Moderna vaccines had shown extraordinary efficacy. "That is nearly to the level of what we see with measles (vaccine), which is 98 per cent effective".

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE